Fever with mild flu-like symptoms was observed in four patients (grade I or grade II), although this symptom was transient and no medication was needed.
For perforin analysis, it was observed that Flu-MP* peptide specific CD8+ T cells from T. cruzi-infected volunteers had similar percentage of expression, ranging from 17.56% to 77.78% (mean 41.4%, SD = 20.60%), than that from the healthy group of donors which ranged from 30.3% to 61.5% (mean 50.62%, SD = 12.05%).
As shown in figure 1A, with the influenza virus M1 primer set a signal of 1.1 kb was observed with the RNA extracted from both FLU-NA-DIII and FLU-NA-GFP virus stocks, while only the DIII primer set resulted in an amplicon of 451 bp with FLU-NA-DIII.
VSMCs apoptosis was observed when the concentration of Flu ranged from 10−4 M to 10−2 M (data not shown).
A 50% ORR with 8% CR rate was obtained among 12 evaluable patients in the Cy-based without Flu group, whereas a 72% ORR with 50% CR rate was observed in the Cy/Flu group (18 evaluable patients).
Further, a correlation was observed between antigenic drift and the number of new influenza cases per year for each flu strain.
Severe pyrexia was observed in 3 out of 194 reports (1.5%) and flu-like symptoms were rated as severe in 7 out of 344 reports (2.0%).
The same was observed following pooling of the normal phase sub-fractions of reversed-phase fraction RP4 (34 nmol FLU eq/g dw).
In flu, cell death is reduced when JA biosynthesis is abolished, but when both OPDA and JA biosynthesis were removed through aos no impact on cell death was observed [ 47].
No difference in arsenic exposure was observed between participants who reported cold/flu/respiratory infection or severe headache compared to women who did not report these symptoms.
A marginal negative association was observed between arsenic quartiles and odds of self-reported cold/flu/infection (P for trend = 0.08).
